WTI futures are trading below $45 per barrel today after the IEA made some gloomy comments on demand growth. Perhaps taking its cue from oil, the broader market is also in the red as all three major indexes are off by more than 1.2% in afternoon trading.
Among the stocks that are underperforming the broader markets are Applied Genetic Technologies Corp (NASDAQ:AGTC), Momo Inc (ADR) (NASDAQ:MOMO), Oasis Petroleum Inc. (NYSE:OAS), Petroleo Brasileiro SA Petrobras (ADR) (NYSE:PBR), and Seadrill Ltd (NYSE:SDRL). In this article, we will take a closer look at the reasons behind the declines of these stocks and assess the smart money sentiment towards them.
We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).
Applied Genetic Technologies Corp (NASDAQ:AGTC) shares are off by over 32% after the company disclosed slower-than-planned enrollment in its XLRS Phase 1/2 Trial, which Applied Genetic is conducting in collaboration with Biogen Inc (NASDAQ:BIIB). So far in August, the company has eight out of the target number of up to 27 patients enrolled. The delays are due to patients not meeting eligibility criteria and due to the company making a protocol amendment to include the use of prophylactic corticosteroids that required further institutional review board approvals.
“The company has not observed any significant improvements in secondary endpoints in the six patients treated at the lowest dose level group. The company does not expect to report further data on the XLRS study this year, but intends to provide quarterly updates on its patient enrollment,” the company said
The secondary endpoints are measured in part to see if there are any early indications of potential efficacy (they are not as important as the primary endpoints, however). In addition, Applied Genetic’s ACHMB3 Phase 1/2 Trial is also experiencing slower-than-expected enrollment due to vendor errors. A total of 12 funds from our database were long Applied Genetic Technologies Corp (NASDAQ:AGTC) at the end of the second quarter, down by two funds from the previous quarter.
Momo Inc (ADR) (NASDAQ:MOMO) shares have lost 6% so far today due to some profit taking. The stock has done very well year-to-date, having gained 50% before today. Given today’s news from the IEA that Chinese crude demand is somewhat soft, some traders are no doubt connecting the dots and anticipating a slower Chinese economic recovery. If that happens, Momo’s growth might not be as strong in dollar terms. According to our data, the number of elite funds with holdings in Momo Inc (ADR) (NASDAQ:MOMO) fell by 1 quarter-over-quarter to 9 at the end of June.
On the next page, we examine what is going on with Oasis Petroleum, Petroleo Brasileiro SA Petrobras, and Seadrill Ltd.